Baxter's infusion pump recall is associated with 9 severe adverse events and more than 3,500 complaints, getting the FDA's attention and highest-risk warning label. Medtech maker Baxter (NYSE:BAX) got the FDA's highest-risk warning after recalling a series of infusion pumps due to a software issue that could lead the devices to malfunction. The recall affects 2 models of Sigma Spectrum Infusion Pumps pumps, manufactured from July 1, 2005, through January 15, 2014.
Help employers find you! Check out all the jobs and post your resume.
